vs
KIRBY CORP（KEX）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
KIRBY CORP的季度营收约是Revvity的1.1倍（$851.8M vs $772.1M），Revvity净利率更高（12.7% vs 10.8%，领先2.0%），KIRBY CORP同比增速更快（6.2% vs 5.9%），KIRBY CORP自由现金流更多（$265.2M vs $161.8M），过去两年Revvity的营收复合增速更高（9.0% vs 2.7%）
总部位于美国得克萨斯州休斯顿的Kirby Corporation是美国最大的罐驳船运营商，业务覆盖密西西比河水系、海湾沿岸航道、美国三大海岸沿线及阿拉斯加、夏威夷地区，主营通过罐驳船运输石化产品、黑油、精炼石油制品、农化产品，同时拥有并运营8组远洋驳船及拖船运输单元。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
KEX vs RVTY — 直观对比
营收规模更大
KEX
是对方的1.1倍
$772.1M
营收增速更快
KEX
高出0.3%
5.9%
净利率更高
RVTY
高出2.0%
10.8%
自由现金流更多
KEX
多$103.4M
$161.8M
两年增速更快
RVTY
近两年复合增速
2.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $851.8M | $772.1M |
| 净利润 | $91.8M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 15.2% | 14.5% |
| 净利率 | 10.8% | 12.7% |
| 营收同比 | 6.2% | 5.9% |
| 净利润同比 | 114.4% | 3.9% |
| 每股收益（稀释后） | $1.68 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KEXRVTY
| Q4 25 | $851.8M | $772.1M | ||
| Q3 25 | $871.2M | $698.9M | ||
| Q2 25 | $855.5M | $720.3M | ||
| Q1 25 | $785.7M | $664.8M | ||
| Q4 24 | $802.3M | $729.4M | ||
| Q3 24 | $831.1M | $684.0M | ||
| Q2 24 | $824.4M | $691.7M | ||
| Q1 24 | $808.0M | $649.9M |
净利润KEXRVTY
| Q4 25 | $91.8M | $98.4M | ||
| Q3 25 | $92.5M | $46.7M | ||
| Q2 25 | $94.3M | $53.9M | ||
| Q1 25 | $76.0M | $42.2M | ||
| Q4 24 | $42.8M | $94.6M | ||
| Q3 24 | $90.0M | $94.4M | ||
| Q2 24 | $83.9M | $55.4M | ||
| Q1 24 | $70.1M | $26.0M |
毛利率KEXRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率KEXRVTY
| Q4 25 | 15.2% | 14.5% | ||
| Q3 25 | 14.8% | 11.7% | ||
| Q2 25 | 15.4% | 12.6% | ||
| Q1 25 | 13.4% | 10.9% | ||
| Q4 24 | 6.3% | 16.3% | ||
| Q3 24 | 15.3% | 14.3% | ||
| Q2 24 | 14.6% | 12.4% | ||
| Q1 24 | 12.6% | 6.8% |
净利率KEXRVTY
| Q4 25 | 10.8% | 12.7% | ||
| Q3 25 | 10.6% | 6.7% | ||
| Q2 25 | 11.0% | 7.5% | ||
| Q1 25 | 9.7% | 6.4% | ||
| Q4 24 | 5.3% | 13.0% | ||
| Q3 24 | 10.8% | 13.8% | ||
| Q2 24 | 10.2% | 8.0% | ||
| Q1 24 | 8.7% | 4.0% |
每股收益（稀释后）KEXRVTY
| Q4 25 | $1.68 | $0.86 | ||
| Q3 25 | $1.65 | $0.40 | ||
| Q2 25 | $1.67 | $0.46 | ||
| Q1 25 | $1.33 | $0.35 | ||
| Q4 24 | $0.74 | $0.77 | ||
| Q3 24 | $1.55 | $0.77 | ||
| Q2 24 | $1.43 | $0.45 | ||
| Q1 24 | $1.19 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.8M | $919.9M |
| 总债务越低越好 | $919.3M | — |
| 股东权益账面价值 | $3.4B | $7.3B |
| 总资产 | $6.0B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.27× | — |
8季度趋势，按日历期对齐
现金及短期投资KEXRVTY
| Q4 25 | $78.8M | $919.9M | ||
| Q3 25 | $47.0M | $931.4M | ||
| Q2 25 | $68.4M | $991.8M | ||
| Q1 25 | $51.1M | $1.1B | ||
| Q4 24 | $74.4M | $1.2B | ||
| Q3 24 | $67.1M | $1.2B | ||
| Q2 24 | $53.5M | $2.0B | ||
| Q1 24 | $75.2M | $1.7B |
总债务KEXRVTY
| Q4 25 | $919.3M | — | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $874.9M | — | ||
| Q3 24 | $978.6M | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $1.1B | — |
股东权益KEXRVTY
| Q4 25 | $3.4B | $7.3B | ||
| Q3 25 | $3.4B | $7.4B | ||
| Q2 25 | $3.4B | $7.6B | ||
| Q1 25 | $3.3B | $7.6B | ||
| Q4 24 | $3.4B | $7.7B | ||
| Q3 24 | $3.3B | $7.9B | ||
| Q2 24 | $3.3B | $7.9B | ||
| Q1 24 | $3.2B | $7.8B |
总资产KEXRVTY
| Q4 25 | $6.0B | $12.2B | ||
| Q3 25 | $6.1B | $12.1B | ||
| Q2 25 | $6.1B | $12.4B | ||
| Q1 25 | $6.0B | $12.4B | ||
| Q4 24 | $5.9B | $12.4B | ||
| Q3 24 | $5.9B | $12.8B | ||
| Q2 24 | $5.9B | $13.4B | ||
| Q1 24 | $5.8B | $13.4B |
负债/权益比KEXRVTY
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 0.32× | — | ||
| Q1 24 | 0.33× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $312.2M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $265.2M | $161.8M |
| 自由现金流率自由现金流/营收 | 31.1% | 21.0% |
| 资本支出强度资本支出/营收 | 5.5% | 2.6% |
| 现金转化率经营现金流/净利润 | 3.40× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $405.7M | $509.4M |
8季度趋势，按日历期对齐
经营现金流KEXRVTY
| Q4 25 | $312.2M | $182.0M | ||
| Q3 25 | $227.5M | $138.5M | ||
| Q2 25 | $93.9M | $134.3M | ||
| Q1 25 | $36.5M | $128.2M | ||
| Q4 24 | $247.4M | $174.2M | ||
| Q3 24 | $206.5M | $147.9M | ||
| Q2 24 | $179.3M | $158.6M | ||
| Q1 24 | $123.3M | $147.6M |
自由现金流KEXRVTY
| Q4 25 | $265.2M | $161.8M | ||
| Q3 25 | $160.3M | $120.0M | ||
| Q2 25 | $22.4M | $115.5M | ||
| Q1 25 | $-42.1M | $112.2M | ||
| Q4 24 | $150.7M | $149.8M | ||
| Q3 24 | $130.1M | $125.6M | ||
| Q2 24 | $90.8M | $136.6M | ||
| Q1 24 | $42.2M | $129.7M |
自由现金流率KEXRVTY
| Q4 25 | 31.1% | 21.0% | ||
| Q3 25 | 18.4% | 17.2% | ||
| Q2 25 | 2.6% | 16.0% | ||
| Q1 25 | -5.4% | 16.9% | ||
| Q4 24 | 18.8% | 20.5% | ||
| Q3 24 | 15.7% | 18.4% | ||
| Q2 24 | 11.0% | 19.7% | ||
| Q1 24 | 5.2% | 20.0% |
资本支出强度KEXRVTY
| Q4 25 | 5.5% | 2.6% | ||
| Q3 25 | 7.7% | 2.6% | ||
| Q2 25 | 8.4% | 2.6% | ||
| Q1 25 | 10.0% | 2.4% | ||
| Q4 24 | 12.0% | 3.4% | ||
| Q3 24 | 9.2% | 3.3% | ||
| Q2 24 | 10.7% | 3.2% | ||
| Q1 24 | 10.0% | 2.7% |
现金转化率KEXRVTY
| Q4 25 | 3.40× | 1.85× | ||
| Q3 25 | 2.46× | 2.97× | ||
| Q2 25 | 1.00× | 2.49× | ||
| Q1 25 | 0.48× | 3.03× | ||
| Q4 24 | 5.78× | 1.84× | ||
| Q3 24 | 2.30× | 1.57× | ||
| Q2 24 | 2.14× | 2.87× | ||
| Q1 24 | 1.76× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KEX
| Inland Transportation | $379.2M | 45% |
| Power Generation | $191.1M | 22% |
| Commercial And Industrial | $149.4M | 18% |
| Coastal Transportation | $102.5M | 12% |
| Oil And Gas | $29.6M | 3% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
